SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-035574
Filing Date
2016-07-25
Accepted
2016-07-25 06:14:52
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atrn20160331_10q.htm 10-Q 621360
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 20112
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 22305
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8971
  Complete submission text file 0001437749-16-035574.txt   3990796

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS atrn-20160331.xml EX-101.INS 582521
6 EXHIBIT 101.SCH atrn-20160331.xsd EX-101.SCH 50254
7 EXHIBIT 101.CAL atrn-20160331_cal.xml EX-101.CAL 25985
8 EXHIBIT 101.DEF atrn-20160331_def.xml EX-101.DEF 441172
9 EXHIBIT 101.LAB atrn-20160331_lab.xml EX-101.LAB 312501
10 EXHIBIT 101.PRE atrn-20160331_pre.xml EX-101.PRE 438476
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-51353 | Film No.: 161780807
SIC: 7389 Services-Business Services, NEC